Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Explores the COVID-19 outbreak, its terminology, transmission, severity, and global impact, emphasizing the importance of mitigation strategies and digital epidemiology.
Explores health challenges in African cities, from infectious diseases to non-communicable diseases and mortality rates, highlighting the need for sustainable urban development.
Introduces the concept of Implementation Research in global health, emphasizing its relevance in addressing significant health problems and improving healthcare delivery.
Explores small molecule drugs for infectious diseases, covering global mortality rates, viral and bacterial injuries, antiviral and antibacterial agents, and the development of COX2 inhibitors.
Explores the promise and problems of implementing interventions for infectious diseases of poverty, emphasizing the need for better access and sustained treatment coverage.
Explores Implementation Research, addressing challenges in implementing health interventions and developing effective strategies for infectious diseases of poverty.
Explores the significance of intersectional gender analysis in implementation research for diseases of poverty, emphasizing transformative goals and inclusivity.
Explores higher-order interactions in brain networks using simplicial complexes and information theory, analyzing data from fMRI, financial time-series, and infectious diseases.
Explores the impact of machine learning in understanding human diseases, focusing on historical significance, natural products discovery, and challenges in designer drugs.
